search again

Nationwide rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $426,580 · 10th–90th $8,710–$436,5160%50%10th90th$426,580Professionalmedian $426,580 · 10th–90th $426,580–$501,1870%50%90th$426,580$1.0$10.0$100.0$1.0K$10.0K$100.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $501,187.23 / $630,957.34

See more rates by state

Want provider-level rates data? We offer custom data extracts for a reasonable fee. To learn more, please email us.